Trials / Terminated
TerminatedNCT02839798
NeoSync TMS Treatment for Bipolar I Depression
Evaluation of NeoSync EEG Synchronized TMS For the Treatment of Major Depressive Episode in Bipolar Disorder and Associated Neural Response: An Open Label Trial
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Butler Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate the safety and preliminary efficacy of synchronized transcranial magnetic stimulation (sTMS) using the NeoSync EEG Synchronized TMS device (NEST) in subjects with Bipolar Disorder type I in a Major Depressive Episode. This is an open label study in which subjects will receive treatment 5 days per week for 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NEST (NeoSync EEG Synchronized TMS) | The NeoSync EEG Synchronized TMS (NEST) is an electromechanical medical device that produces and delivers a sinusoidal magnetic field to areas of the brain in the treatment of Bipolar Depression. |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2018-11-19
- Completion
- 2018-11-19
- First posted
- 2016-07-21
- Last updated
- 2020-04-09
- Results posted
- 2020-04-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02839798. Inclusion in this directory is not an endorsement.